Metenolone Enanthate 200 - Livewell Pharmaceuticals

Methenolone enanthate’s early release as Nibal Depot in 1962 was short-lived in the U.S., but its transfer to Schering led to broader adoption in European medicine. As Primobolan Depot, the drug offered a unique profile: mild anabolic effect, low androgenicity, and no conversion to estrogen. It was used clinically in patients recovering from illness, trauma, or surgery, where long-term therapy with minimal hormonal disruption was needed. Its enanthate ester extended its effect, reducing injection frequency while maintaining stable blood levels.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Metenolone Enanthate 200 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.